Under the Horizon Europe research and innovation programme 2021-2027, five EU missions have been launched to bring concrete solutions to some of the current greatest challenges, including Mission Cancer.
The overarching goal of the EU Cancer Mission is to improve the lives of more than 3 million people by 2030 through prevention, cure and for those affected by cancer, including their families, to live longer and better.
The deadline for the all the topics is 18th of Septembre, 2024
With a total budget of 119 million euros, Mission Cancer has several topics, here 2 of them:
It will focus on validating, testing and scaling up easy-to-use genetic, multi-omics or other biomarker-based tests for the early detection of cancers with an underlying inherited genetic risk, with a view to their adoption in regional or national health systems.
The projects should be between the TRL 5 and 7.
With a budget of 35 million euros, The Commission estimates that an EU contribution of between EUR 10.00 and 12.00 million would allow these outcomes to be addressed appropriately.
This topic will contribute to the achievement of the Mission’s objective to improve the quality of life of cancer patients, survivors, and their families. The focus should be exclusively on adolescent and young adult (AYA, age range 15-39) cancer patients and survivors.
Any legal entity regardless of its profit/non-profit status or annual turnover, which is established in an EU Member State, or HE associated country, may receive funding from EU Cancer Mission.
In order for a consortium to be considered eligible, it should include:
• at least one independent legal entity established in a Member State; and
• at least two other independent legal entities, each established in different Member States or associated countries.
This topic will have a budget of 36 million euros, and the Commission estimates that an EU contribution of between EUR 4.00 and 6.00 million would allow these outcomes to be addressed appropriately.
In order for a consortium to be considered eligible, it must include:
• at least one independent legal entity established in a Member State; and
• at least two other independent legal entities, each established in different Member States or associated countries.
FI Group has 20 years of experience and wants to accompany you on the new NextGenerationEU path. Our experts are at your disposal to analyse how your project fits into the NextGenerationEU European recovery fund and to take the next steps together with you. Contact us.
Copyright 2022 FI Group all rights reserved. - Terms of Use - Data Subject Rights - Cookies Policy
